Resverlogix Corp.

That is a plausible scenario, DND. If Resverlogix were about to be sold, or control given up, Zenith shareholders would have only one last chance to secure royalty rights to the whole portfolio, especially if you worried that the current APOA1 perfomance based approach of the agreement was "flawed" and making it difficult or impossible to qualify for a royalty. I could imagine that there would be a very strong urge for a last grab and secure.

The "grab" as I will call it, may also be a bluff, a poision pill tactic in reverse if you will. "Buy us at $X now or the portfolio revenue potential left over is only going to get smaller." Possible or plausible? Thoughts?